![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 25, 23643-23652, June 24, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in Its Protective Effect Against Tumor Necrosis Factor-related Apoptosis Inducing Ligand-induced Apoptosis*







||
From the
Gonda (Goldschmied) Medical Diagnosis Research Center, Faculty of Life-Sciences, Bar-Ilan University, Ramat-Gan, Israel 52900, the
Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, Michigan 48202, and the ¶Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI, National Institutes of Health, Bethesda, Maryland 20892
Protein kinase C
(PKC
) regulates cell apoptosis in a cell- and stimulus-specific manner. Here, we studied the role of PKC
in the apoptotic effect of TRAIL in glioma cells. We found that transfection of the cells with a PKC
kinase-dead mutant (K376R) or with a small interfering RNA targeting the PKC
mRNA increased the apoptotic effect of tumor necrosis factor-related apoptosis inducing ligand (TRAIL), whereas overexpression of PKC
decreased it. PKC
acted downstream of caspase 8 and upstream of cytochrome c release from the mitochondria. TRAIL induced cleavage of PKC
within 23 h of treatment, which was abolished by caspase 3, 8, and 9 inhibitors. The cleavage of PKC
was essential for its protective effect because overexpression of a caspase-resistant mutant (PKC
D327A) did not protect glioma cells from TRAIL-induced apoptosis but rather increased it. TRAIL induced translocation of PKC
to the perinuclear region and the endoplasmic reticulum and phosphorylation of PKC
on tyrosine 155. Using a PKC
Y155F mutant, we found that the phosphorylation of PKC
on tyrosine 155 was essential for the cleavage of PKC
in response to TRAIL and for its translocation to the endoplasmic reticulum. In addition, phosphorylation of PKC
on tyrosine 155 was necessary for the activation of AKT in response to TRAIL. Our results indicate that PKC
protects glioma cells from the apoptosis induced by TRAIL and implicate the phosphorylation of PKC
on tyrosine 155 and its cleavage as essential factors in the anti-apoptotic effect of PKC
.
Received for publication, February 7, 2005 , and in revised form, March 15, 2005.
* This work was supported by a grant from the James S. McDonnell Foundation 21st Century Scientist Award/Brain Cancer Research (to C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| To whom correspondence should be addressed: Hermelin Brain Tumor Center, Dept. of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202. E-mail: chaya{at}mail.biu.ac.il.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. L. Lomonaco, S. Kahana, M. Blass, Y. Brody, H. Okhrimenko, C. Xiang, S. Finniss, P. M. Blumberg, H.-K. Lee, and C. Brodie Phosphorylation of Protein Kinase C{delta} on Distinct Tyrosine Residues Induces Sustained Activation of Erk1/2 via Down-regulation of MKP-1: ROLE IN THE APOPTOTIC EFFECT OF ETOPOSIDE J. Biol. Chem., June 20, 2008; 283(25): 17731 - 17739. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gomel, C. Xiang, S. Finniss, H. K. Lee, W. Lu, H. Okhrimenko, and C. Brodie The Localization of Protein Kinase C{delta} in Different Subcellular Sites Affects Its Proapoptotic and Antiapoptotic Functions and the Activation of Distinct Downstream Signaling Pathways Mol. Cancer Res., June 1, 2007; 5(6): 627 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xia, L. W. Forman, and D. V. Faller Protein Kinase C{delta} Is Required for Survival of Cells Expressing Activated p21RAS J. Biol. Chem., May 4, 2007; 282(18): 13199 - 13210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Choi, T. Hyman, and P. M. Blumberg Differential Effect of Bryostatin 1 and Phorbol 12-Myristate 13-Acetate on HOP-92 Cell Proliferation Is Mediated by Down-regulation of Protein Kinase C{delta}. Cancer Res., July 15, 2006; 66(14): 7261 - 7269. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Billecke, S. Finniss, L. Tahash, C. Miller, T. Mikkelsen, N. P. Farrell, and O. Bogler Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma Neuro-oncol, July 1, 2006; 8(3): 215 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rosenzweig, A. Ziv-Av, C. Xiang, W. Lu, S. Cazacu, D. Taler, C. G. Miller, R. Reich, Y. Shoshan, Y. Anikster, et al. Related to Testes-Specific, Vespid, and Pathogenesis Protein-1 (RTVP-1) Is Overexpressed in Gliomas and Regulates the Growth, Survival, and Invasion of Glioma Cells. Cancer Res., April 15, 2006; 66(8): 4139 - 4148. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |